GlassScriptPhysician profile
Dang H Vu
NPI 1083674659
$4,166.97
in general payments reported to CMS, 2019-2025
12 companies · $1,542 in 2025
The $1,542 reported for 2025 was more than what 87% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,009 · 2022: $103 · 2023: $58.45 · 2024: $1,455 · 2025: $1,542.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,855 · Food and Beverage: $1,189 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,855.33 |
| Food and Beverage | $1,188.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,578.01 | 2024-2025 | |
| Smith+Nephew, INC. | $581.93 | 2019-2025 | Collagenase Santyl |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $226.42 | 2019 | |
| Amgen INC. | $208.78 | 2024-2025 | Krystexxa |
| Sanara Medtech INC. | $149.87 | 2024 | Celleraterx |
| Stryker Corporation | $149.22 | 2019-2023 | T2 Alpha, Asnis |
| Horizon Therapeutics Plc | $116.07 | 2019 | |
| Sandoz INC. | $69.35 | 2019 | |
| Paratek Pharmaceuticals, INC. | $37.65 | 2022-2024 | Nuzyra |
| Abbvie INC. | $22.58 | 2023 | Dalvance |
| Sebela Pharmaceuticals INC. | $15.31 | 2022 | |
| Bioventus LLC | $11.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dang Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.